Physostigmine
Antidote/antagonist for intoxication (tropane alkaloids, tricyclic antidepressants,..., Postoperative disorders (Central anticholinergic syndrome, delayed awakening, shivering)
Indications
- Antidote/antagonist for intoxication (tropane alkaloids, tricyclic antidepressants,...
- Postoperative disorders (Central anticholinergic syndrome, delayed awakening, shivering)
Adult dosing
- postop disorders: dose: 0.04; unit: mg/kg; route: IV; interval: 5-20 minutes; weightBased: true; maxDose: 2; maxDoseAbsolute: true; labelExcerpt: Slowly inject physostigmine intravenously at a dose of 0.04 mg/kg bodyweight (approx. 1 mg/min), the maximum individual dose is 2 mg. In case of insufficient effect, give subsequent injections after 5 to 20 minutes at the earliest, after a positive evaluation of the effect of the first injection.
Pediatric dosing
- intoxication: dose: 0.5; unit: mg; route: IV; interval: 5 minutes; fixed: true; labelExcerpt: Infants: Start with a low dose of 0.5 mg of physostigmine salicylate administered intravenously, repeat this dose every 5 minutes up to the overall dose of 2 mg, as long as the toxic, anticholinergic symptoms continue to persist, and no cholinergic symptoms occur.
Renal adjustment
- Consult pharmacy/current label
Hepatic adjustment
- Consult pharmacy/current label
Contraindications
- Hypersensitivity to physostigmine
- Bronchial asthma
- Coronary heart disease
- Intestinal obstruction
- Intoxication with irreversible cholinesterase inhibitors or barbiturates
Clinical pearls
- Administer intravenously slowly or as a brief infusion over 10-15 minutes.
- Adequate dosing is indicated by the recovery of mental abilities and responsiveness.
- Perform a risk/benefit analysis for patients with diabetes, bradycardia, or Parkinson's disease.
- When treating tricyclic antidepressant intoxication, continuous ECG monitoring is required due to risk of cardiac arrest.
Source and review
- DailyMed label (physostigmine salicylate, ANTICHOLIUM), Set ID b90b50e8-c8f1-4f2d-be6e-4d269b8c362c, effective 2025-11-11. Last reviewed: 2026-11-11
RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties